UNIVERSITY OF CALIFORNIA SAN DIEGO

• SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

  UEI MMLKPW9JLX64

  $5.1M

  Subcontractor to this prime · 2 sub-awards · latest Mar 3, 2025

  • Department of the Navy
  • Washington Headquarters Services
  • “THE SUBCONTRACTOR WILL BE ASSIGNED WORK ACTIVITIES AND PRODUCTS BY THE PRIME CONTRACTOR UNDER TASK 1 AND TASKS 3 THROUGH 8 IN THE PWS 3.0 (TASKS). THE SUBCONTRACTORS ASSIGNMENTS WILL CONCENTRATE IN, BUT NOT BE LIMITED TO, PWS SECTION 3.5 (CYBER SECURITY) WORK DUE TO ITS EXPERTISE AND EXPERIENCES WITH CYBERSECURITY AND ACCREDITATION.”
  • “CONDUCT AERIAL FLYOVERS OF 19 NAVY AND MARINE CORPS INSTALLATIONS TO CAPTURE HIGH-RESOLUTION LIDAR POINT CLOUD, HYPERSPECTRAL IMAGERY, SHORT WAVE INFRARED DATA, VIDEO, AND DIGITAL SINGLE LENS REFLEX IMAGERY AT THE SPECIFICATIONS PROVIDED BY THE GOVERNMENT IN THE SOW. THESE DATA WILL BE IN AF FORMAT AND RESOLUTION TO INTEGRATE WITH FLOODPLAIN ANALYSIS DECISION SUPPORT TOOLS DEVELOPED BY SCRIPPS INSTITUTE. DELIVERED DATA ARE TO BE FORMATTED FOR USE IN ARCGIS PRO GIS SOFTWARE.”
• TRIAD NATIONAL SECURITY, LLC

  UEI X7WUS5LRBQU3

  $375K

  Subcontractor to this prime · 1 sub-award · latest Mar 18, 2024

  • Department of Energy
  • “UNIVERSITY OF CALIFORNIA SAN DIEGO-STANDALONE-ITEM LEVEL-CONTINGENT LABOR AND HUMAN RESOURCE SERVICES”
• HDR ENVIRONMENTAL, OPERATIONS AND CONSTRUCTION, INC.

  UEI EKCVZLXL4MA8

  $100K

  Subcontractor to this prime · 1 sub-award · latest Sep 30, 2026

  • Bureau of Ocean Energy Management
  • “DATA ANALYSIS TASKS”

• UNIVERSITY OF MONTANA

  UEI DAY7Z8ZD48Q3 · not in the directory yet

  $1.2M

  Subcontracted by this company · 1 sub-award · latest Dec 8, 2023

  • National Institutes of Health
  • “MOD: 275,318.00 MOD: 405,043.00 SUB:513,116.00 SECTION 3: STATEMENT OF WORK 3.1. SCOPE CURRENT VACCINES AGAINST SEASONAL INFLUENZA VIRUS INFECTION REDUCE INFLUENZA ILLNESS BY 40- 60% AMONG THE TOTAL POPULATION. HOWEVER, THE VACCINE PROTECTION IS INSUFFICIENT WHEN THE CIRCULATING INFLUENZA STRAINS DO NOT MATCH THE ONES IN THE SEASONAL VACCINES, AND THE PATIENTS ARE IN IMMUNOCOMPROMISED POPULATIONS LEADING ONLY TO LIMITED PROTECTION AGAINST HOMOLOGOUS VIRUS STRAINS. SUCH GAPS BETWEEN VACCINATED STRAINS AND CIRCULATING STRAINS LOWER THE VACCINE EFFECTIVENESS RESULTING IN SEASONAL EPIDEMICS. ADDITIONALLY, NEUTRALIZING ANTIBODY LEVELS INDUCED BY THE VACCINES DO NOT RELIABLY PERSIST YEAR-ROUND. THUS, THE ADJUVANT DEVELOPMENT CONTRACT PROPOSED HEREIN WILL ADVANCE A NOVEL SMALL MOLECULE DUAL ADJUVANT SYSTEM WITH TLR4 AND TLR7 AGONISTIC ADJUVANTS COMBINED WITH AN INFLUENZA VACCINE TO OBTAIN AN ADJUVANTED VACCINE THAT WILL INDUCE RAPID AND SUSTAINED BROADLY PROTECTIVE IMMUNITY TO SEASONAL AND/OR PANDEMIC INFLUENZA VIRUS. THIS”

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).

The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.